Pharmafile Logo
Pharmafocus logo
Advanced Search

2010 financials

Showing 5 posts of 20 posts found.

Teva reports strong Q1 results

May 10, 2010
Sales and Marketing 2010 financials, Teva

Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …

News

Lundbeck delivers strong results and builds on pipeline

May 7, 2010
2010 financials, Azilect, Lundbeck

Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …

News

Pfizer and Merck post modest results

May 6, 2010
Sales and Marketing 2010 financials, Merck, Pfizer

The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine.  Both …

News

Novartis shines in first quarter

April 21, 2010
Sales and Marketing 2010 financials, Alcon, Novartis

Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …

News

Lilly faces substantial costs from US health reform

April 20, 2010
Sales and Marketing 2010 financials, Obama, lilly

Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026